Inmunoregulacion
Madrid, ES · 1 known investors
Find your way into Inmunoregulacion
Sign up to see every warm intro you have to Inmunoregulacion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inmunoregulacion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
The Laboratory of Immuno-Regulation (LIR) is a research group at the Gregorio Marañón Hospital Health Research Institute in Madrid that studies regulatory T cells and thymic tissue for treating autoimmune diseases and transplant rejection. Its work includes cell-based therapies and has led to a biotech spin-off, Thytech.
Investors · 1
Frequently asked questions
- What does Inmunoregulacion do?
- The Laboratory of Immuno-Regulation (LIR) is a research group at the Gregorio Marañón Hospital Health Research Institute in Madrid that studies regulatory T cells and thymic tissue for treating autoimmune diseases and transplant rejection. Its work includes cell-based therapies and has led to a biotech spin-off, Thytech.
- Who are Inmunoregulacion's investors?
- Inmunoregulacion's investors include BStartup.
- Where is Inmunoregulacion headquartered?
- Inmunoregulacion is headquartered in Madrid, ES.
